phrykt

NeuroPace Inc (NPCE): who owns it and who trades it

As of Nov 16, 2026, NPCE insiders reported 1 open-market sale worth $399K and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Martha Morrell (CHIEF MEDICAL OFFICER), with $399K. 5 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling NeuroPace

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns NPCE

113 funds and institutions reported NPCE shares worth $424M at the end of Q2 2026, about 79% of the company. The largest holder is Polar Capital Holdings Plc with 9.8%.

Funds and institutions (13F) 79%Everyone else 21%

10 largest owners, by share of the company

Polar Capital Holdings Plc9.8%
Soleus Capital Management, L.P.8.6%
First Light Asset Management, LLC8.5%
Morgan Stanley7.9%
BlackRock, Inc.7.4%
Orbimed Advisors LLC4.5%
Driehaus Capital Management LLC4.3%
Vanguard Capital Management LLC3.6%
Deutsche Bank Ag\2.8%
Armistice Capital, LLC2.1%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Polar Capital Holdings Plc3.30M9.80%$52.4MNo change
Soleus Capital Management, L.P.2.91M8.65%$46.3M-1%
First Light Asset Management, LLC2.86M8.50%$45.5M+16%
Morgan Stanley2.65M7.88%$42.2M+3%
BlackRock, Inc.2.48M7.36%$39.4M+6%
Orbimed Advisors LLC1.51M4.47%$23.9M-28%
Driehaus Capital Management LLC1.45M4.30%$23M-0%
Vanguard Capital Management LLC1.23M3.64%$19.5M+9%
Deutsche Bank Ag\938,9192.79%$14.9M+1%
Armistice Capital, LLC692,0002.06%$11MNo change
Geode Capital Management, LLC666,3001.98%$10.6M+8%
FMR LLC (Fidelity)554,7711.65%$8.8M+0%
State Street Corp550,1321.63%$8.7M+11%
Silvercrest Asset Management Group LLC344,1241.02%$5.5M-4%
Northern Trust Corp260,0250.77%$4.1M+8%
Qube Research & Technologies Ltd221,2370.66%$3.5M+19%
Vanguard Portfolio Management LLC220,3710.65%$3.5M+18%
Palumbo Wealth Management LLC209,1990.62%$3.3M-1%
Essex Investment Management Co LLC208,7030.62%$3.3M-4%
Algert Global LLC184,7740.55%$2.9M+3%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, NPCE insiders reported $0 of open-market purchases and $399K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$399K
1 trades, 1 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Dec 15, 2025
Filed Mar 4, 2026

Purchases and sales by month

$399K$399KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Dec 15, 2025Martha MorrellCHIEF MEDICAL OFFICERSale25,000$15.97$399KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Martha MorrellCHIEF MEDICAL OFFICER–$399KDec 15, 2025
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

NPCE short interest

Low short interest. 2.5% of NPCE shares are sold short: about 1 share in 40. Over the last 12 reports the number of shares short went up 40%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 858,343 NPCE shares were sold short, 2.5% of the shares outstanding, down 3.1% from the report before. At the average daily volume of 101,274 shares, buying them all back would take about 8.5 trading days (days to cover).

Shares short, % of all shares

2.50%May 15Oct 302.94%

Days to cover

8.5May 15Oct 309.7

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026858,3432.50%-3%101,2748.5
Oct 15, 2026886,2302.58%-2%107,1388.3
Sep 30, 2026903,6262.63%-6%146,3036.2
Sep 15, 2026956,2212.79%+5%109,7368.7
Aug 31, 2026911,4152.66%+8%145,0586.3
Aug 14, 2026845,3692.46%+3%253,4663.3
Jul 31, 2026822,1262.44%-6%208,7643.9
Jul 15, 2026874,3372.60%-3%153,2685.7
Jun 30, 2026898,5872.67%+47%228,8213.9
Jun 15, 2026612,8291.82%+5%137,7874.5
May 29, 2026582,9431.73%-5%148,7043.9
May 15, 2026613,8171.82%-21%266,3242.3

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

NeuroPace company events

NeuroPace filed 5 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Aug 11, 2026.

  1. Aug 11, 2026ResultsReleased financial results. Filing
  2. Jul 28, 2026AnnouncementShared information with investors. Filing
  3. Jun 8, 2026VoteReported shareholder vote results. Filing
  4. May 12, 2026ResultsReleased financial results. Filing
  5. Mar 3, 2026ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

NeuroPace financials

Famous investors that hold NPCE

5 of the 50 well-known investors we track reported holding NPCE in their latest 13F filing. The largest position is Ken Griffin's, worth $3.4M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 2026247,158$3.4M0.0%+92%
Paul Tudor Jones · Tudor Investment CorpQ3 2026143,233$2M0.0%+30%
Israel Englander · Millennium ManagementQ3 202651,078$703K0.0%+67%
Jim Simons · Renaissance TechnologiesQ3 202643,700$601K0.0%-61%
Steve Cohen · Point72 Asset ManagementQ3 202628,843$397K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about NeuroPace Inc (NPCE) stock

Who owns the most NPCE stock?

The largest reported owner of NeuroPace Inc (NPCE) is Polar Capital Holdings Plc, with 9.8% of the company. In total, 113 funds and institutions reported holding NPCE at the end of Q2 2026, together about 79% of the shares. See the largest owners.

Are NPCE insiders buying or selling?

In the last 12 months, NPCE insiders reported no open-market purchases and 1 sale worth $399K. The latest trade was on Dec 15, 2025. See every trade.

What is the short interest in NPCE?

As of Oct 30, 2026, 858,343 NPCE shares were sold short, 2.5% of the shares outstanding, down 3.1% from the report before. At the average daily volume of 101,274 shares, buying them all back would take about 8.5 trading days (days to cover). See the history.

Which famous investors hold NPCE?

5 of the 50 well-known investors we track reported NPCE in their latest 13F filing, including Ken Griffin, Paul Tudor Jones, Israel Englander. The largest position is worth $3.4M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.